Skip to search.
 TSX Down 0.70% TSX Ventures Down 0.47%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
3.04 Down 0.04(1.30%) Jul 25, 4:00PM EDT
Prev Close:3.08
Open:3.08
Bid:2.12 x 100
Ask:4.47 x 500
1y Target Est:6.75
Beta:3.26236
Next Earnings Date: 4-Aug-16BCRX Earnings announcement
Day's Range:2.99 - 3.08
52wk Range:1.63 - 15.96
Volume:295,390
Avg Vol (3m):708,648
Market Cap:224.03M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
BCRXDown 1.30%224.03M
GSKUp 0.36%106.97B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.91
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.06
Quarterly EPS Est (Jun-16) :-0.26
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.14

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback